Product Code: RP-ID-10078275 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10078275
Market Overview:
Stem Cell Industry By Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells),By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy ), and By Application (Musculoskeletal Disorders, Wounds and Injuries, Cardiovascular Diseases) - Global Market Size Analysis and Forecast 2019-2025
Global Stem Cell Therapy Industry was valued at USD 105.24 Million in the year 2017. Global Stem Cell Therapy Industry is further estimated to grow at a CAGR of 12.33% from 2018 to reach USD 266.72 Million by the year 2025. North America region holds the highest Industry share in 2017 and the Industry is also considered as the fastest growing Industry in the forecasted period. At a country level, the U.S. is projected to grow strongly in the coming years. The growth is attributed to the presence of key Industry players, growing awareness of the stem cell usage in the various application in disorders such as central nervous system disorders, cardiovascular diseases, neurodegenerative diseases, metabolic, eye, and immune system.
Major market Stem Cell Therapy Industry are Medipost Co. Ltd., Anterogen Co. Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate Srl, JCR Pharmaceuticals Co., Ltd., Osiris Therapeutics, Inc., Nuvasive, Inc., RTI Surgical, Inc., and other 10 companies information is provided in research report. Organic growth techniques such as expanding global presence along with increasing research and development activities to address the changing demand of the healthcare industry were few techniques adopted by most of Tier 1 and Tier 2 manufacturers in recent years.
SWOT Analysis of Stem Cell Therapy Industry:
Strength:
Growing Awareness Related to the Therapeutic Potency and effectiveness for Infection Management
Growing Public-Private Investment models for the Expansion of the Stem Cell Therapies in the developed regions
Weakness:
Varied Regulatory Guidelines across regions pertaining to for new Product Development.
Opportunities:
Government supportive regulations across regions for the use of stem cell in improving the disease management.
Threats:
Low Awareness in emerging Industry due to the Technical Limitations
Stem Cell Therapy Industry on the basis of various application, the autologous stem cell therapy is further subcategorized into cardiovascular diseases, wounds, and injuries, gastrointestinal diseases. The allogeneic stem cell therapy segment is estimated to grow at the highest CAGR till 2025. This growth is attributed to the growing usage of the allogeneic stem cell therapy products along with its broad therapeutic uses.
Stem Cell Therapy Industry Segmentation:
By Type
• Allogeneic Stem Cell Therapy Industry, By Application
o Musculoskeletal Disorders
o Wounds and Injuries
o Surgeries
o Acute Graft-Versus-Host Disease (AGVHD)
• Autologous Stem Cell Therapy Industry, By Application
o Wounds and Injuries
o Cardiovascular Diseases
o Gastrointestinal Diseases
By Cell Source
• Adipose Tissue-Derived Mesenchymal Stem Cells
• Bone Marrow-Derived Mesenchymal Stem Cells
• Cord Blood/Embryonic Stem Cells
By Application
• Musculoskeletal Disorders
• Wounds and Injuries
• Cardiovascular Diseases
• Surgeries
• Gastrointestinal Diseases
By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
Related Reports
Proof of Quality & Reliability
